Sign Out
Pregnancy: There is no indication for use of GONAL-f during pregnancy. Data on a limited number of exposed pregnancies (less than 300 pregnancy outcomes) indicate no malformative or feto/neonatal toxicity of follitropin alfa.
No teratogenic effect has been observed in animal studies (see Pharmacology: Toxicology: Preclinical safety data under Actions).
In case of exposure during pregnancy, clinical data are not sufficient to exclude a teratogenic effect of GONAL-f.
Breastfeeding: GONAL-f is not indicated during breastfeeding. During lactation, the secretion of prolactin can result in a poor prognosis to ovarian stimulation.
Lanjutkan dengan Google